Salient features Experience and Capabilities    

The Pre-clinical Services offered by Reliance comprises in-vivo efficacy and pre-clinical safety studies for cell-based therapies, proteins and chemical entities. The facility, which is OECD certified, is located at the Dhirubhai Ambani Life Sciences Centre, Navi Mumbai.

Salient features: 

  • State-of-the-art, barrier maintained facility with robust environmental monitoring system
  • Class 10,000 animal rooms for immuno-deficient mice colonies
  • Dedicated high vacuum autoclaves for feed and cage sterilization
  • Studies in compliance with OECD principles of GLP
  • Chronic studies in Specific Pathogen Free animals
  • Fully automated clinical and histopathology laboratory with highly skilled pathologists and technicians
  • Highly qualified professionals experienced in GLP certified labs to conduct toxicity studies
  • Independent QA team to conduct study, process and facility based inspections

Our experience and capabilities include:

  • Regulatory Toxicology

    General Toxicology

    -Mutagenicity Studies
    -Acute Toxicology Studies
    -Sub-Chronic Toxicity Studies
    -Chronic Toxicity Studies by Oral Parenteral   Routes

    Local Tissue Tolerance Studies -Sensitization Studies
    -Skin Irritation Studies
    Mutagenicity Studies -In vitro: Ames test
    -In vivo: Micronucleus and Chromosomal   Aberration test

  • Bio efficacy studies of biotechnologically derived products

  • Medical device testing as per ISO 10993

  • Specialized Animal Services
    • Studies in SPF rodents and immuno-deficient mice
    • Generation of monoclonal/polyclonal antibodies
    • Development of animal models for human diseases
    • Genetic monitoring of inbred rats and mice
    • Microbial monitoring of rodents
    • Supply of specific surgical rodent models
    • Bioassays and Pyrogen testing
    • Advanced training courses in mouse breeding
Reliance LARS is registered with the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) and conforms to its guidelines.